Professor Ronit Satchi-Fainaro‘s lab at the Faculty of Medical and Health Sciences at Tel Aviv University (TAU) collaborated with Professor Helena Florindo’s lab at the University of Lisbon to produce a novel nano-vaccine for COVID-19. The nano-vaccine, a 200-nanometer particle, trains the immune system against all common COVID-19 variants just as effectively as existing vaccines…. Read More
Researchers at Tel Aviv University (TAU) have determined that the NMDA receptor (NMDAR) in the brain, long studied primarily for its role in learning and memory, also plays a crucial role in stabilizing brain activity. By setting the “baseline” level for activity in neural networks, the NMDAR helps maintain stable brain function amidst continuous environmental… Read More
Researchers at Tel Aviv University (TAU) have found that a variant of the TMEM16F protein, caused by a genetic mutation, enhances the spread of Parkinson’s pathology through nerve cells in the brain. The researchers say that their discovery of a new factor in the pathology of Parkinson’s disease may serve as a target for developing… Read More
Researchers at Tel Aviv University (TAU) and the Sagol Center for Hyperbaric Medicine and Research at the Shamir Medical Center have demonstrated that hyperbaric oxygen therapy (HBOT) improves the condition of PTSD sufferers who have not responded to psychotherapy or psychiatric medications. The researchers say that their unique therapeutic protocol affects the biological brain “wound”… Read More
A technological breakthrough by medical researchers at Tel Aviv University (TAU) enabled the discovery of a cancer mechanism that prevents the immune system from attacking tumors. The researchers were surprised to find that reversing this mechanism stimulates the immune system to fight the cancer cells, even in types of cancer considered resistant to prevailing forms… Read More
Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University (TAU), in collaboration with the European Institute of Oncology in Milan, have extensively examined the characteristics of aneuploid cells, which have an abnormal number of chromosomes, and raised findings that may advance new cancer treatments. According to the researchers, “A… Read More
Researchers at Tel Aviv University (TAU) in cooperation with three major Israeli medical centers have developed a new method for detecting protein aggregation in cells, a hallmark of Parkinson’s disease. The technology can enable diagnosis up to 20 years before the first motor symptoms appear, facilitating treatment or even prevention of the severe disease, which… Read More
A new technological development from Tel Aviv University (TAU) can monitor changes in pupil size and gaze direction behind closed eyes using touchless infrared imaging. Tracking changes in pupil size can help identify a state of wakefulness in sleep, anesthesia, and intensive care and help track the depth of sedation, detect seizures and nightmares, and… Read More